Location Raleigh, North Carolina, United States Regions Research Triangle, East Coast, Southern US Gender Male
LinkedIn View on LinkedIn
Dr. Stocker is Executive Director of Clinical Development for Tetherex. He has more than 15 years of experience in drug discovery and clinical research. Dr. Stocker was previously Executive Director of Clinical Development for Selexys Pharmaceuticals from 2012 to 2016. Prior to joining Selexys, he held positions of increasing responsibility at
Icagen, Inc. a biopharmaceutical company focused on ion channel drug development, where he spent more than 6 years leading Icagen's sickle cell disease drug development program. He has expertise in translational research, specifically in the design and implementation of early phase proof-of-concept clinical research studies. Dr. Stocker has authored more than 30 clinical protocols and has more than 20 publications in peer-reviewed scientific journals. Dr. Stocker received his doctorate degree in biophysical chemistry from the Department of Chemistry at Stanford University. Dr. Stocker continued his training as a Postdoctoral Visiting Scholar in the Physiology Department at Keio University School of Medicine, Tokyo followed by a Postdoctoral Research Fellowship in the Department of Molecular and Cellular Physiology at the Stanford School of Medicine.
